← Back to Search

Nonsteroidal Anti-inflammatory Drug

Naproxen for Heterotopic Ossification

Phase < 1
Waitlist Available
Led By Stephen Aoki, M.D.
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 75 days after surgery
Awards & highlights

Study Summary

In a brief summary the study would like to evaluate the effectiveness of Naproxen in preventing radiographically detected heterotopic ossification following hip arthroscopy for the treatment of femoroacetabular impingement.

Eligible Conditions
  • Heterotopic Ossification

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~75 days after surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and 75 days after surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participants with documented Heterotopic Ossification (HO) in the Naproxen group vs Placebo group
Secondary outcome measures
Naproxen

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: NaproxenActive Control1 Intervention
• Group 1: Naproxen 500 mg twice daily for three weeks following surgery beginning postoperative day #1
Group II: PlaceboPlacebo Group1 Intervention
• Group 2: Placebo twice daily for three weeks following surgery beginning postoperative day #1

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor
1,099 Previous Clinical Trials
1,778,581 Total Patients Enrolled
Stephen Aoki, M.D.Principal InvestigatorUniversity of Utah Orthopedics Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Influence of Naproxen on Heterotropic Bone Formation Following Hip Arthroscopy
Stephen Aoki 2012. "Influence of Naproxen on Heterotropic Bone Formation Following Hip Arthroscopy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01539447.
~8 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top